发明名称 |
Compositions and methods of therapy for IGF-I-responsive conditions |
摘要 |
Compositions and methods useful in therapy for IGF-I-responsive conditions in a mammal are provided. The method comprises concurrent therapy with both IGF-I or a variant thereof and at least one GAG to promote a desired therapeutic response with respect to a particular IGF-I-responsive condition. Concurrent therapy is achieved by administering to a mammal a single pharmaceutical composition containing both IGF-I (or a variant thereof) and at least one GAG according to a dosing regimen. Alternatively, IGF-I or a variant thereof and at least one GAG can be administered as two separate pharmaceutical compositions. A pharmaceutical composition comprising IGF-I or a variant thereof and at least one GAG for use in the IGF-I and GAG therapy is also provided.
|
申请公布号 |
US2003100505(A1) |
申请公布日期 |
2003.05.29 |
申请号 |
US20020279343 |
申请日期 |
2002.10.24 |
申请人 |
CHIRON CORPORATION |
发明人 |
SCHARSCHMIDT BRUCE F.;GORIO ALFREDO;MULLER EUGENIO E. |
分类号 |
A61K31/727;A61K31/737;A61K38/30;(IPC1-7):A61K38/30 |
主分类号 |
A61K31/727 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|